EUVIMEDEUVIMED entdecken
Crossref

Huanglian Wendan ameliorates depression via gut-brain axis-related PPAR-α/allo pathways

Qingya Sun, Yijing Zhao, Jiayan Zhang, Ruonan Shuang, Wei Li, Wenjie Huang, Chang Chen, Fan Zhao, Xiaolan Cheng, Weiwei Tao

Phytomedicine · 2026-08 · 158 · 158332

DOI: 10.1016/j.phymed.2026.158332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-08. Verfasst von Qingya Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing City, Jiangsu Province 210023, China. Hauptthemen laut MEDLINE: PPAR alpha, Depression, Drugs, Chinese Herbal, Brain-Gut Axis. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Huanglian Wendan decoction (HLWD) is traditionally used to treat a syndrome characterized by symptoms such as insomnia, irritability, and digestive disturbances. Its historical application in addressing phlegm-heat-induced mental and emotional disorders offers both a cultural and clinical basis for investigating its potential mechanisms in alleviating depressive symptoms via gut-brain axis. PURPOSE: To explore the potential therapeutic mechanisms of HLWD in improving depression. METHODS: Behavioral outcomes were assessed using the SPT, TST, OFT, and SIT. Neurogenesis was evaluated by measuring dendritic length and neuronal intersections. Allopregnanolone levels were measured using ELISA. Inflammatory signaling pathways (TLR4, MyD88, NF-κB) and cytokines (IL-1β, TNF-α, IL-10, IL-4) in the hippocampus were analyzed via WB. The integrity of the intestinal barrier was further validated through immunofluorescence and histological examination. Finally, GW6471 was employed to investigate whether PPAR-α mediates the effects of HLWD. RESULTS: The UPLC analysis identified 42 constituents, primarily comprising flavonoids, alkaloids, and coumarins. Behavioral assays demonstrated that HLWD effectively ameliorated depressive-like behaviors in mice. Mechanistically, HLWD elevated the levels of DCX-positive neurogenesis markers, inhibited microglial activation, protected the intestinal mucosal barrier, and reduced inflammatory responses in both the colon and hippocampus. The RNA-seq results indicated an enrichment of the PPAR signaling pathway in colon. Consistent with this finding, HLWD significantly upregulated both the protein and mRNA levels of PPAR-α in the colon. Meanwhile, it increased the concentration of allopregnanolone in hippocampal via peripheral circulation. Notably, the administration of the PPAR-α antagonist GW6471 reversed these neuroprotective effects and the associated protein changes, thereby underscoring the critical role of PPAR-α in the therapeutic mechanism of HLWD. CONCLUSION: HLWD can elevate the levels of PPAR-α and allopregnanolone in the colon, subsequently influencing the levels of allopregnanolone in the hippocampus via peripheral circulation. This process may enhance neurological function and alleviate depressive symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaDepressionDrugs, Chinese HerbalBrain-Gut AxisAnimalsMaleMiceNeurogenesisSignal TransductionHippocampusPregnanoloneCytokinesMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

AllopregnanoloneDepressionGut-brain axisPPAR-αTCM

Substanzen

PPAR alphaDrugs, Chinese HerbalPregnanoloneCytokinesoren gedoku toPpara protein, mouse

Autor:innen und Institutionen

  • School of Integrated Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing City, Jiangsu Province 210023, China.
  • School of Integrated Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing City, Jiangsu Province 210023, China. Electronic address: 290180@njucm.edu.cn.
  • School of Integrated Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing City, Jiangsu Province 210023, China. Electronic address: chengxiaolan37@njucm.edu.cn.
  • School of Integrated Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing City, Jiangsu Province 210023, China; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializa…

Förderung

  • National Administration of Traditional Chinese Medicine

Zitieren

APA

Sun, Q., Zhao, Y., Zhang, J., Shuang, R., Li, W., Huang, W., Chen, C., Zhao, F., Cheng, X., & Tao, W. (2026). Huanglian Wendan ameliorates depression via gut-brain axis-related PPAR-α/allo pathways. Phytomedicine, 158, 158332. https://doi.org/10.1016/j.phymed.2026.158332

Vancouver

Sun Q, Zhao Y, Zhang J, Shuang R, Li W, Huang W, et al. Huanglian Wendan ameliorates depression via gut-brain axis-related PPAR-α/allo pathways. Phytomedicine. 2026;158:158332. doi:10.1016/j.phymed.2026.158332

BibTeX
@article{Sun2026,
  author = {Sun, Qingya and Zhao, Yijing and Zhang, Jiayan and Shuang, Ruonan and Li, Wei and Huang, Wenjie and Chen, Chang and Zhao, Fan and Cheng, Xiaolan and Tao, Weiwei},
  title = {Huanglian Wendan ameliorates depression via gut-brain axis-related PPAR-α/allo pathways},
  journal = {Phytomedicine},
  year = {2026},
  volume = {158},
  pages = {158332},
  doi = {10.1016/j.phymed.2026.158332}
}
Kostenlos starten →